Gideon Shapiro
Corporate Officer/Principal at BRIGHT MINDS BIOSCIENCES INC.
Net worth: 324 632 $ as of 2024-06-29
Profile
Gideon Shapiro is the founder of Somatocor Pharmaceuticals, Inc., EraGen Biosciences, Inc. He is currently the Vice President-Discovery at Bright Minds Biosciences, Inc. He was previously the Chief Science Officer at Rugen Therapeutics and Vice President-Chemistry at FORUM Pharmaceuticals, Inc.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-12-21 | 299,200 ( 6.70% ) | 324 632 $ | 2024-06-29 |
Gideon Shapiro active positions
| Companies | Position | Start |
|---|---|---|
| BRIGHT MINDS BIOSCIENCES INC. | Corporate Officer/Principal | 2020-09-28 |
Former positions of Gideon Shapiro
| Companies | Position | End |
|---|---|---|
| Rugen Therapeutics | Corporate Officer/Principal | 2018-12-31 |
| Somatocor Pharmaceuticals, Inc. | Founder | - |
FORUM Pharmaceuticals, Inc.
 FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | Corporate Officer/Principal | - |
EraGen Biosciences, Inc.
 EraGen Biosciences, Inc. Medical SpecialtiesHealth Technology EraGen Biosciences, Inc. is a venture-backed biotechnology company. It designs, develops, manufactures and markets molecular diagnostic testing products and software for the research and clinical testing markets. The firm in-market and pipeline products, based on its novel, patented MultiCode platform chemistry, are the next generation of nucleic acid-based testing for the early detection and monitoring of cancer, genetic and infectious diseases. The company was founded in 1994 and is headquartered in Madison WI. | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | Health Technology |
EraGen Biosciences, Inc.
EraGen Biosciences, Inc. Medical SpecialtiesHealth Technology EraGen Biosciences, Inc. is a venture-backed biotechnology company. It designs, develops, manufactures and markets molecular diagnostic testing products and software for the research and clinical testing markets. The firm in-market and pipeline products, based on its novel, patented MultiCode platform chemistry, are the next generation of nucleic acid-based testing for the early detection and monitoring of cancer, genetic and infectious diseases. The company was founded in 1994 and is headquartered in Madison WI. | Health Technology |
| Somatocor Pharmaceuticals, Inc. | |
| Rugen Therapeutics | |
| Bright Minds Biosciences, Inc. |
- Stock Market
- Insiders
- Gideon Shapiro
